Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on May 01, 2024 1:18pm
60 Views
Post# 36017734

RE:With 2 steps forward, 1 step back

RE:With 2 steps forward, 1 step backwith LABS it is never 2 steps forward 1 step back, it's 1 step forward 1 step back or 1 step forward 2 steps back.

LABS isn't CGC or TLRY, but CGC is up plenty since March and what is happening to them, one could argue, is 2 steps forward one step back.

Given we're trading within the same bounds as we have for literally years, there is no apparent forward progress of note yet.  This is the main task of Pidduck IMO, finally making good on shareholder value progression in a tangible way and not by buying revenue but by posting results that will make the markets notice and drive the SP.

A share buyback would be another ballsy coming out party move as well.

<< Previous
Bullboard Posts
Next >>